What is AC-150B 0.005% used for?

AC-150B 0.005% is indicated for Treatment of mild to moderate atopic dermatitis.

Who makes AC-150B 0.005%?

AC-150B 0.005% is developed by Aciex Therapeutics, Inc..

What are the side effects of AC-150B 0.005%?

Common side effects include Skin atrophy.

Last reviewed 2026-04-23 · How we verify

AC-150B 0.005%

Aciex Therapeutics, Inc. · Phase 2 active Small molecule

AC-150B 0.005% is a topical corticosteroid used to reduce inflammation and itching.

AC-150B 0.005% is a topical corticosteroid used to reduce inflammation and itching. Used for Treatment of mild to moderate atopic dermatitis.

At a glance

Generic name	AC-150B 0.005%
Sponsor	Aciex Therapeutics, Inc.
Drug class	topical corticosteroid
Modality	Small molecule
Therapeutic area	Dermatology
Phase	Phase 2

Mechanism of action

It works by inhibiting the production of pro-inflammatory cytokines and reducing the activity of immune cells in the skin. This leads to a decrease in inflammation and itching, providing relief to patients with skin conditions.

Approved indications

Treatment of mild to moderate atopic dermatitis

Common side effects

Skin atrophy

Key clinical trials

Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results